NRG Oncology Network Group Operations Center

NRG管理核心NRG肿瘤学(NRG)管理核心提供必要的领导和基础设施，以支持NCI国家临床试验网络(NCTN)中成人群体中最大的临床试验组合，成员包括220多个主要成员站点-包括几乎每个领先的学术参与站点(LAPS)，并为NCTN的整体管理和成功做出强有力的贡献。NRG利用一个非常成功的多PI模式，提供非常有能力的领导和科学监督，充满活力的委员会领导和指导，知识和经验丰富的行政和运营领导，以及适当的相关支持。NRG是四年前才成立的一个小组，它利用其遗留小组的优势形成了一个综合的现代临床试验组织，面向NCTN内的特定人群。值得注意的是，NRG在所有领域都保持着很高的生产力，即使在三个遗产集团的合并中也是如此，这证明了NRG卓越的领导能力和深思熟虑的组织结构。除了支持自己的目标外，NRG还是NCTN高度合作的成员。NRG与其他小组共同领导了许多试验，支持其他小组的16项研究，参加了NCI指定的许多指导委员会、工作组和特别工作组，并领导开发了新的远程监测标准。NRG拥有领导力和基础设施，可以继续支持临床试验和成员目标，并继续作为利益相关者参与NCTN的整体管理和成功。

NRG Administrative Core Abstract The NRG Oncology (NRG) Administrative Core provides the leadership and infrastructure necessary to support the largest portfolio of clinical trials among the adult groups in the NCI National Clinical Trail Network (NCTN), a membership encompassing over 220 main member sites – including nearly every Lead Academic Participating Site (LAPS) and a robust contribution to the overall management and success of the NCTN. NRG utilizes a highly successful multiple-PI model to provide remarkably capable leadership and scientific oversight, dynamic committee leadership and mentoring, knowledgeable and experienced administrative and operational leadership, and appropriate associated support. NRG, a group formed only four years ago, has leveraged the strengths of its legacy groups to form an integrated, modern clinical trials organization addressing specific populations within the NCTN. It is notable that NRG remained highly productive in all realms even while navigating the merger of the three legacy groups, a testament to the remarkable leadership of NRG and the thoughtful organizational structure put into place. In addition to supporting its own goals, NRG is a highly collaborative member of the NCTN. NRG co-led a number of trials with other groups, championed sixteen studies from other groups, participated in numerous NCI-appointed steering committees, workgroups, and task forces, and led the development of new remote monitoring standards. NRG has the leadership and infrastructure in place to continue to support the clinical trial and membership goals as well as continue to serve as engaged stakeholders in the overall management and success of the NCTN.